CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
CN Stock MarketDetailed Quotes
603520 Zhejiang Starry Pharmaceutical
- 8.42
- +0.30+3.69%
Market Closed Apr 30 15:00 CST
3.69BMarket Cap-78.69P/E (TTM)
8.56High8.12Low145.34KlotVolume8.14Open8.12Pre Close121.74MTurnover3.32%Turnover RatioLossP/E (Static)438.41MShares13.0852wk High1.40P/B3.69BFloat Cap7.3252wk Low8.93Limit Up438.41MShs Float69.39Historical High7.31Limit Down5.42%Amplitude4.72Historical Low0.05Dividend TTM8.38Avg Price53.11KlotAsk0.59%Div YieldTTM100Lot Size88.02KlotBid
Zhejiang Starry Pharmaceutical Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 6.79%685.9M | 7.02%2.35B | 10.65%1.8B | 22.75%1.33B | 13.50%642.3M | 3.04%2.2B | 18.43%1.63B | 15.00%1.08B | 9.40%565.91M | 6.57%2.13B |
| Operating revenue | 6.79%685.9M | 7.02%2.35B | 10.65%1.8B | 22.75%1.33B | 13.50%642.3M | 3.04%2.2B | 18.43%1.63B | 15.00%1.08B | 9.40%565.91M | 6.57%2.13B |
| Other operating revenue | ---- | 68.21%337.09M | ---- | 14.84%152.87M | ---- | -23.98%200.4M | ---- | -1.08%133.12M | ---- | 108.06%263.61M |
| Total operating cost | 6.48%663.55M | 12.31%2.4B | 12.28%1.79B | 22.67%1.29B | 12.28%623.18M | 2.06%2.14B | 14.67%1.59B | 17.11%1.05B | 25.53%555.02M | 29.84%2.1B |
| Operating cost | 12.80%563.48M | 13.88%1.89B | 14.85%1.42B | 26.07%1.04B | 11.06%499.54M | 2.71%1.66B | 20.98%1.23B | 24.29%828.49M | 26.55%449.8M | 29.30%1.62B |
| Operating tax surcharges | -2.68%4.6M | 4.09%19.2M | -5.01%13.87M | -11.68%9.46M | -13.06%4.72M | 26.74%18.45M | 26.11%14.6M | 26.63%10.72M | 2.30%5.43M | -6.36%14.56M |
| Operating expense | 5.79%27.05M | 28.15%127.03M | 45.96%93.8M | 52.26%63.94M | 34.90%25.57M | 39.98%99.13M | 13.60%64.27M | 18.29%42M | 221.76%18.95M | 259.88%70.81M |
| Administration expense | -2.39%29.67M | -8.13%117.48M | 2.19%93.39M | -0.63%60.2M | 17.78%30.4M | -12.11%127.87M | -14.05%91.38M | -13.96%60.58M | -26.49%25.81M | 11.15%145.49M |
| Financial expense | -36.38%19.61M | 8.49%104.68M | -14.75%72.39M | 10.43%52.3M | 52.75%30.82M | -15.20%96.49M | -14.22%84.92M | -17.71%47.36M | 62.43%20.18M | 58.61%113.79M |
| -Interest expense (Financial expense) | -10.94%23.97M | -6.28%96.16M | -12.89%69.07M | -2.00%49.06M | 3.95%26.91M | 10.80%102.6M | 23.97%79.29M | 23.75%50.07M | 70.69%25.89M | 25.44%92.6M |
| -Interest Income (Financial expense) | 32.24%-1.57M | -11.37%-8.41M | -33.15%-7.11M | -22.44%-4.8M | -9.35%-2.31M | 22.17%-7.55M | 26.36%-5.34M | 44.18%-3.92M | -111.00%-2.12M | -70.06%-9.7M |
| Research and development | -40.40%19.15M | 4.54%140.67M | -5.75%97.59M | -3.47%62.91M | -7.81%32.12M | 1.47%134.56M | 8.46%103.55M | 5.50%65.17M | 24.58%34.84M | 6.44%132.61M |
| Credit Impairment Loss | -77.40%-9.23M | -91.36%768.96K | -137.16%-1.56M | -453.77%-12.36M | -125.31%-5.2M | 1,289.31%8.9M | 82.95%4.2M | 201.32%3.49M | 62.58%-2.31M | 92.13%-747.97K |
| Asset Impairment Loss | -174.41%-5.09M | -22.28%-36.05M | -45.85%-15M | 13.20%-5.82M | -239.47%-1.86M | 76.34%-29.48M | -1,743.26%-10.28M | -1,010.59%-6.71M | ---546.77K | -3,834.39%-124.61M |
| Other net revenue | -2,122.95%-6.33M | 84.71%-1.17M | -87.98%679.47K | -258.30%-8.59M | 131.65%312.71K | 91.61%-7.63M | -89.79%5.65M | -87.92%5.42M | -105.36%-987.96K | -739.36%-90.98M |
| Fair value change income | ---- | ---- | ---23.15K | ---23.15K | 94.97%-23.15K | -97.36%23.15K | ---- | ---- | ---460.54K | 453.18%876.69K |
| Invest income | 91.76%-377.4K | 32.00%-9.61M | -141.55%-12.37M | -226.25%-12.36M | -259.01%-4.58M | -229.22%-14.13M | -118.00%-5.12M | -113.27%-3.79M | -110.36%-1.28M | 51.22%10.93M |
| -Including: Investment income associates | 68.56%-377.4K | 34.06%-6.58M | 0.83%-4.76M | 3.04%-2.95M | -20.87%-1.2M | -505.29%-9.98M | -13,810.97%-4.8M | -3,008.29%-3.05M | -913.65%-993.16K | -189.94%-1.65M |
| Asset deal income | -77.39%59.1K | -99.81%6.7K | -83.21%614.71K | -92.49%261.33K | 986.79%261.33K | 1,121.09%3.53M | -19.92%3.66M | -23.89%3.48M | -99.44%24.05K | 89.64%-345.94K |
| Other revenue | -29.00%8.31M | 85.80%43.71M | 119.94%29.01M | 142.68%21.72M | 227.17%11.71M | 2.65%23.53M | -32.59%13.19M | -43.42%8.95M | -55.23%3.58M | 0.28%22.92M |
| Operating profit | -17.59%16.01M | -208.79%-53.51M | -62.03%16.52M | -18.35%28.58M | 96.28%19.43M | 188.17%49.19M | 0.60%43.52M | -59.81%35M | -89.42%9.9M | -113.96%-55.79M |
| Add:Non operating Income | 86.75%557.11K | 491.58%1.21M | 216.66%569.56K | 230.57%462.46K | 1,830.20%298.31K | -79.95%204.35K | -69.62%179.87K | -71.02%139.9K | -87.77%15.46K | -50.32%1.02M |
| Less:Non operating expense | -73.28%314.75K | 20.36%4.87M | -3.74%2.29M | -26.09%1.38M | 445.09%1.18M | -61.98%4.04M | -60.06%2.38M | -58.56%1.87M | -84.35%216.12K | 65.50%10.63M |
| Total profit | -12.38%16.26M | -226.06%-57.17M | -64.18%14.8M | -16.87%27.66M | 91.27%18.55M | 169.34%45.35M | 9.04%41.32M | -59.94%33.27M | -89.49%9.7M | -116.54%-65.4M |
| Less:Income tax cost | -66.80%1.99M | -1,110.01%-8.07M | 204.62%5.56M | 324.25%4.48M | 1,501.14%5.99M | -87.76%798.82K | -79.13%1.82M | -114.51%-2M | -93.43%374.24K | -90.06%6.53M |
| Net profit | 13.58%14.27M | -210.21%-49.1M | -76.59%9.25M | -34.28%23.18M | 34.69%12.56M | 161.94%44.55M | 35.48%39.5M | -49.10%35.27M | -89.23%9.33M | -121.81%-71.93M |
| Net profit from continuing operation | 13.58%14.27M | -210.21%-49.1M | -76.59%9.25M | -34.28%23.18M | 34.69%12.56M | 161.94%44.55M | 35.48%39.5M | -49.10%35.27M | -89.23%9.33M | -121.81%-71.93M |
| Less:Minority Profit | -127.55%-76.78K | -101.26%-4.04K | 50.57%269.23K | 5,111.93%282.88K | 215.22%278.73K | -91.80%321.26K | -98.14%178.81K | -100.11%-5.64K | -103.79%-241.92K | -34.82%3.92M |
| Net profit of parent company owners | 16.79%14.34M | -211.00%-49.1M | -77.17%8.98M | -35.09%22.9M | 28.37%12.28M | 158.32%44.23M | 101.17%39.32M | -44.95%35.28M | -88.08%9.57M | -123.43%-75.85M |
| Earning per share | ||||||||||
| Basic earning per share | -25.00%0.03 | -192.31%-0.12 | -81.82%0.02 | -40.00%0.06 | 33.33%0.04 | 159.09%0.13 | 83.33%0.11 | -47.37%0.1 | -87.50%0.03 | -123.40%-0.22 |
| Diluted earning per share | -25.00%0.03 | -192.31%-0.12 | -81.82%0.02 | -40.00%0.06 | 33.33%0.04 | 159.09%0.13 | 83.33%0.11 | -47.37%0.1 | -87.50%0.03 | -123.16%-0.22 |
| Other composite income | 14.52%-1.65M | 282.00%17.91M | -206.63%-3.27M | -124.30%-1.95M | -912.79%-1.93M | -206.44%-9.84M | -70.68%3.07M | 68.15%8.03M | 108.17%237.87K | 392.20%9.25M |
| Other composite income of parent company owners | 14.52%-1.65M | 282.00%17.91M | -206.63%-3.27M | -124.30%-1.95M | -912.79%-1.93M | -206.44%-9.84M | -70.68%3.07M | 68.15%8.03M | 108.17%237.87K | 392.20%9.25M |
| Total composite income | 18.70%12.61M | -189.85%-31.19M | -85.97%5.97M | -50.97%21.23M | 11.13%10.63M | 155.37%34.71M | 7.43%42.57M | -41.54%43.3M | -88.58%9.56M | -119.19%-62.68M |
| Total composite income of parent company owners | 22.63%12.69M | -190.68%-31.18M | -86.55%5.7M | -51.63%20.95M | 5.54%10.35M | 151.63%34.39M | 41.22%42.39M | -37.11%43.31M | -87.32%9.81M | -120.77%-66.6M |
| Total composite income of minority owners | -127.55%-76.78K | -101.26%-4.04K | 50.57%269.23K | 5,111.93%282.88K | 215.22%278.73K | -91.80%321.26K | -98.14%178.81K | -100.11%-5.64K | -103.79%-241.92K | -34.82%3.92M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.